John P. Konhilas, Ph.D
MenoLabs Co-Founder
Co-Founders Danielle Jacobs and Vanessa Ford, both mothers, wives and successful professionals launched MenoLabs with Co-Founder, John P. Konhilas, Ph.D. an Associate Professor with the Department of Physiology and Sarver Molecular Cardiovascular Research at the University of Arizona. Doctor Konhilas is listed as lead researcher on a number of revolutionary new DuPont Probiotic patents including Bifidobacterium animalis ssp. Lactis 420 and has published a large body of work related to menopause and cardiovascular disease, women's health when aging, the gut microbiome, and the effect of probiotics in reducing the symptoms of menopause.
Scientific Biography
20+ Years of Research
According to the CDC (2017) more women than men have died from heart disease over the last 20-25 years. Clearly, menopause is a major factor driving these statistics. Unfortunately, this fact is largely unknown even by well-informed women. In fact, the National Institutes of Health and the American Heart Association do not have a separate institute or focus group that studies menopause. These are major reasons why I do research. I began my research career studying heart disease immediately after completing my undergraduate degree at Duke University in 1992.
"For the last 20 years, my lab has been trying to understand why more women have died from heart disease than men. I quickly learned that, in general, women are underrepresented in clinical studies. In addition, studies intended to understand this difference between women and men were poorly designed."
Since arriving at the University of Arizona, we have been instrumental in using a unique model of menopause to build a better understanding of cardiovascular disease in women. More importantly, our lab soon discovered that the gut microbiome plays a major role in menopausal susceptibility to heart disease and health in general. These 2 major discoveries have shaped my research and reflect the cutting-edge, transformational and translational science that we continue today.
Research Interests
Innovative and Cutting-edge
Our Probiotics
"These innovative and cutting-edge formulations represent 20+ years of our research along with the most current, evidence-based ingredients to support women's menopausal health."
